【结 构 式】 |
【药物名称】Tamsulosin hydrochloride, Amsulosin hydrochloride, Y-617, YM-12617-1, LY-253351, YM-617, EU-617, Josir, Omix, Harnal, Flomax, Alna, Flomax MR, Omic, Omnic, Pradif 【化学名称】(-)-(R)-5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide hydrochloride 【CA登记号】106463-17-6, 106133-20-4 (free base), 80223-99-0 (racemate) 【 分 子 式 】C20H29ClN2O5S 【 分 子 量 】444.98153 |
【开发单位】Yamanouchi (Originator), Boehringer Ingelheim (Licensee), Abbott (Comarketer), National Institutes of Health (Codevelopment) 【药理作用】Benign Prostatic Hyperplasia Therapy, RENAL-UROLOGIC DRUGS, Urologic Drugs, alpha1-Adrenoceptor Antagonists |
合成路线1
A new synthesis of YM-12617-1, the active R-isomer of YM-12617, has been described: The reductocondensation of 1-(4-methoxyphenyl)-2-propanone (I) with R-1-phenylethylamine (II) gives regioselectively the secondary amine (III) as the HCl salt, which by sulfonation with chlorosulfonic acid and treatment with NH4OH yields (R,R)-2-methoxy-5-[2-(1-phenylethylamino)propyl]benzenesulfonamide (IV). Eliminating the protecting group by hydrogenation, the free amine hydrochloride (V) is obtained, which is finally submitted to a reductocondensation with 2-(2-ethoxyphenoxy)acetaldehyde (VI) by means of sodium borohydride in methanol, and treated with HCl in ether.
【1】 Hunden, D.C.; Wheller, W.J.; Schmiegel, K.K.; The synthesis of the 14C and 2H-isotopomers of (R)-N-[2-(2'-ethoxyphenoxy)-ethyl]-N-2-[3-(4'-methoxy-3'-sulfonamido)-phenyl]-propylamine hydrochloride, an alpha1-adrenoreceptor antagonist. J Label Compd Radiopharm 1989, 26, 2, 171. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10038 | 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone | 122-84-9 | C10H12O2 | 详情 | 详情 |
(II) | 10039 | (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine | 3886-69-9 | C8H11N | 详情 | 详情 |
(III) | 10040 | (2R)-1-(4-Methoxyphenyl)-N-[(1R)-1-phenylethyl]-2-propanamine; N-[(1R)-2-(4-Methoxyphenyl)-1-methylethyl]-N-[(1R)-1-phenylethyl]amine | C18H23NO | 详情 | 详情 | |
(IV) | 10041 | 2-Methoxy-5-((2R)-2-[[(1R)-1-phenylethyl]amino]propyl)benzenesulfonamide | C18H24N2O3S | 详情 | 详情 | |
(V) | 10042 | 5-[(2R)-2-Aminopropyl]-2-methoxybenzenesulfonamide | 112101-81-2 | C10H16N2O3S | 详情 | 详情 |
(VI) | 10043 | 2-(2-Ethoxyphenoxy)acetaldehyde | 103181-55-1 | C10H12O3 | 详情 | 详情 |
合成路线2
The condensation of 2-methoxy-5-(2-bromopropionyl)benzenesulfonamide (I) with N-benzyl-2-(2 ethoxyphenoxy)ethylamine (II) in refluxing butanone gives the tertiary amine (III), which is reduced with sodium in ethanol to the alcohol (IV). Debenzylation of (IV) with H2 over Pd/C in methanol affords the hydroxyamine (V), which by reaction with SOCl2 in acetonitrile is converted to the corresponding chloro derivative (VI). Finally, this compound is dechlorinated by hydrogenolysis with H2 over Pd/C in methanol.
【1】 Niigata, K.; Fujikura, T. (Yamanouchi Pharmaceutical Co., Ltd.); Sulfamoyl-substd. phenethylamine derivs., their preparation, and pharmaceutical compsns., containing them. EP 0034432; US 4373106; US 5447958 . |
【2】 Fujikura, T.; et al. (Yamanouchi Pharmaceutical Co., Ltd.); Phenylethanolamine derivatives. DE 2843016; ES 474149; ES 481549; FR 2405931; GB 2006772 . |
【3】 Castaner, J.; Mannhold, R.; YM-12617. Drugs Fut 1986, 11, 4, 293. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 24025 | 5-(2-bromopropanoyl)-2-methoxybenzenesulfonamide | C10H12BrNO4S | 详情 | 详情 | |
(II) | 24026 | N-benzyl-2-(2-ethoxyphenoxy)-1-ethanamine | C17H21NO2 | 详情 | 详情 | |
(III) | 24027 | 5-(2-[benzyl[2-(2-ethoxyphenoxy)ethyl]amino]propanoyl)-2-methoxybenzenesulfonamide | C27H32N2O6S | 详情 | 详情 | |
(IV) | 24028 | 5-(2-[benzyl[2-(2-ethoxyphenoxy)ethyl]amino]-1-hydroxypropyl)-2-methoxybenzenesulfonamide | C27H34N2O6S | 详情 | 详情 | |
(V) | 24029 | 5-(2-[[2-(2-ethoxyphenoxy)ethyl]amino]-1-hydroxypropyl)-2-methoxybenzenesulfonamide | C20H28N2O6S | 详情 | 详情 | |
(VI) | 24030 | 5-(1-chloro-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl)-2-methoxybenzenesulfonamide | C20H27ClN2O5S | 详情 | 详情 |